<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28246019</identifier>
<setSpec>1885-5857</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Madonna, Rosalinda</dc:author>
<dc:description xml:lang="en">Heart failure due to antineoplastic therapy remains a major cause of morbidity and mortality in oncological patients. These patients often have no prior manifestation of disease. There is therefore a need for accurate identification of individuals at risk of such events before the appearance of clinical manifestations. The present article aims to provide an overview of cardiac imaging as well as new "-omics" technologies, especially with regard to genomics and proteomics as promising tools for the early detection and prediction of cardiotoxicity and individual responses to antineoplastic drugs.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Imagen cardiaca</dc:subject>
<dc:subject>Cardiac imaging</dc:subject>
<dc:subject>Cardiotoxicidad</dc:subject>
<dc:subject>Terapia antineoplásica</dc:subject>
<dc:subject>Omics</dc:subject>
<dc:subject>Tecnología «ómica»</dc:subject>
<dc:subject>Cardiotoxicity</dc:subject>
<dc:subject>Anticancer therapy</dc:subject>
<dc:date>2017 Jul </dc:date>
<dc:title xml:lang="en">Early Diagnosis and Prediction of Anticancer Drug-induced Cardiotoxicity: From Cardiac Imaging to "Omics" Technologies.</dc:title>
<dc:publisher>Revista espanola de cardiologia (English ed.)</dc:publisher>
</metadata>
</record>
</pubmed-document>
